Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Thymidine Phosphorylase Exerts Complex Effects on Bone Resorption and Formation in Myeloma

Huan Liu, PhD, Zhiqiang Liu, PhD, Juan Du, MD, Jin He, M.S., Pei Lin, MD, Amini Behrang, MD, Michael W Starbuck, M.S., Nora M Novane, MD, Jatin J. Shah, MD, Richard Eric Davis, MD, Jian Hou, MD, Robert Gagel, MD, Jing Yang, PhD

Blood (2016) 128 (22): 1135.

https://doi.org/10.1182/blood.V128.22.1135.1135

Published: 2016

Journal Articles

Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML

Qi Zhang, MD PhD, Lina Han, MD PhD, Ce Shi, MD PhD, Rongqing Pan, MS, Man Chun John MA, PhD, Jeremy Ryan, PhD, Stephen E Kurtz, PhD, Hong Mu, MD PhD, Vivian Ruvolo, MS, Helen Ma, MS, Michael Andreeff, MD PhD, Yingchang Mi, MD PhD, Jeffrey W. Tyner, PhD, Joel Leverson, Anthony Letai, MD PhD, Richard Eric Davis, MD, Marina Konopleva, MD PhD

Blood (2016) 128 (22): 101.

https://doi.org/10.1182/blood.V128.22.101.101

Published: 2016

Journal Articles

Silencing TG2 in Acute Myeloid Leukemia. Possible Role of TG2 in Microenvironment-Mediated Chemoresistance

Rodrigo Omar Jacamo, PhD, Qi Zhang, MD PhD, Teresa McQueen, MS, Richard Eric Davis, MD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 5087.

https://doi.org/10.1182/blood.V128.22.5087.5087

Published: 2016

Journal Articles

Gene Expression Profiling Predicts Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Catherine M Claussen, MS, Hans Lee, MD, Jatin J. Shah, MD, Tiffany Richards, ANP, Nina Shah, MD, Krina Patel, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Sheeba Thomas, MD, Yago Nieto, MD PhD, Muzaffar H. Qazilbash, MD, Richard Eric Davis, MD, Sattva S. Neelapu, MD, Donna M. Weber, MD, Robert Z. Orlowski, PhD, MD, Lei Feng, MS, Elisabet E. Manasanch, MD

Blood (2016) 128 (22): 5628.

https://doi.org/10.1182/blood.V128.22.5628.5628

Published: 2016

Journal Articles

Molecular Aspects of Tonic B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma Provide Biomarkers and Targets for Specific Inhibition

Ondrej Havranek, MD PhD, Jingda Xu, PhD, Stefan Koehrer, MD, Zhiqiang Wang, PhD, Justin M Comer, Lisa Becker, Allen F Yi, Jan A. Burger, MD PhD, Jason R. Westin, MD, Tomasz Zal, PhD, Richard Eric Davis, MD

Blood (2016) 128 (22): 779.

https://doi.org/10.1182/blood.V128.22.779.779

Published: 2016

Journal Articles

The Risk of Central Nervous System (CNS) Relapses in Patients with Peripheral T-Cell Lymphoma

Dai Chihara, MD PhD, Michelle A Fanale, MD, Roberto N. Miranda, MD, Mansoor Noorani, Jason R. Westin, MD, Loretta J. Nastoupil, MD, Fredrick B. Hagemeister, MD, Luis E. Fayad, MD, Jorge E. Romaguera, MD, Felipe Samaniego, MD, Francesco Turturro, MD, Hun Ju Lee, MD, Sattva S. Neelapu, MD, Alma Rodriguez, MD, Michael Wang, MD, Nathan Fowler, MD, L. Jeffrey Medeiros, MD, Richard Eric Davis, MD, Yasuhiro Oki, MD

Blood (2016) 128 (22): 4153.

https://doi.org/10.1182/blood.V128.22.4153.4153

Published: 2016

Journal Articles

ONC201 Overcomes Chemotherapy Resistance By Upregulation of Bim in Multiple Myeloma

Yong-sheng Tu, PhD, Jin He, M.S., Huan Liu, PhD, Richard Eric Davis, MD, Robert Z. Orlowski, MD, PhD, Joshua E Allen, PhD, Jing Yang, PhD

Blood (2016) 128 (22): 4476.

https://doi.org/10.1182/blood.V128.22.4476.4476

Published: 2016

Journal Articles

ONC212 Is a Potent Member of the Imipridone Class of Anti-Cancer Compounds That Induces p53-Independent Apoptosis in Hematological Malignancies

Takenobu Nii, PhD, Jo Ishizawa, MD PhD, Ran Zhao, Jianfang Zeng, MD PhD, Dhruv Chachad, Kensuke Kojima, MD PhD, Marina Konopleva, MD PhD, Richard Eric Davis, MD, Joshua E Allen, PhD, Martin Stogniew, PhD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 4059.

https://doi.org/10.1182/blood.V128.22.4059.4059

Published: 2016

Journal Articles

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience

Blood (2016) 128 (22): 4208.

https://doi.org/10.1182/blood.V128.22.4208.4208

Published: 2016

Journal Articles

The Survival Outcome of the Patients with Relapsed/Refractory Anaplastic Large-Cell Lymphoma

Blood (2015) 126 (23): 2738.

https://doi.org/10.1182/blood.V126.23.2738.2738

Published: 2015

Journal Articles

Management Strategies and Outcomes for Very Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Dai Chihara, MD PhD, Mohamed Amin Ahmed, MD, Yasuhiro Oki, MD, Jason R Westin, MD, Fredrick B. Hagemeister, MD, Jorge E. Romaguera, MD, Michelle A. Fanale, Hun Ju Lee, MD, Francesco Turturro, MD, Felipe Samaniego, MD, Sattva S. Neelapu, MD, Alma Rodriguez, MD, Nathan Fowler, MD, Michael Wang, MD, Luis E. Fayad, MD, Richard Eric Davis, MD, Loretta Nastoupil, MD

Blood (2015) 126 (23): 1502.

https://doi.org/10.1182/blood.V126.23.1502.1502

Published: 2015

Journal Articles

Use of Gene Expression Profiling May Predict Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Catherine M Claussen, MS, Tammy Chuang, Jatin Shah, MD, Hans Lee, MD, Nina Shah, MD, Krina K Patel, Qaiser Bashir, MD, Simrit Parmar, MD, Sheeba Thomas, MD, Muzaffar Qazilbash, MD, Richard Eric Davis, MD, Sattva S. Neelapu, MD, Donna Weber, MD, Robert Z. Orlowski, PhD, MD, Lei Feng, MS, Elisabet E. Manasanch, MD

Blood (2015) 126 (23): 5390.

https://doi.org/10.1182/blood.V126.23.5390.5390

Published: 2015

Journal Articles

RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma

Hans Lee, MD, Hua Wang, PhD, Heather Lin, M.S., Veera Baladandayuthapani, PhD, Jin He, Richard Julian Jones, PhD, Isere Kuiatse, PhD, Dongmin Gu, MD, PhD, Zhiqiang Wang, PhD, Sean O'Brien, PhD, Jonathan J Keats, PhD, Jing Yang, PhD, Richard Eric Davis, MD, Robert Z. Orlowski, PhD, MD

Blood (2015) 126 (23): 3010.

https://doi.org/10.1182/blood.V126.23.3010.3010

Published: 2015

Journal Articles

ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response

Blood (2015) 126 (23): 2051.

https://doi.org/10.1182/blood.V126.23.2051.2051

Published: 2015

Journal Articles

The Survival Outcome of the Patients with Relapsed/Refractory PTCL-NOS and AITL

Blood (2015) 126 (23): 3984.

https://doi.org/10.1182/blood.V126.23.3984.3984

Published: 2015

Journal Articles

The Clinical Outcome of Newly Diagnosed Patients >60 Years of Age with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Standard or Liposomal Chemotherapies

Mohamed Amin Ahmed, MD, Yasuhiro Oki, MD, Mansoor Noorani, Loretta Nastoupil, MD, Luis E. Fayad, MD, Fredrick B. Hagemeister, MD, Alma Rodriguez, MD, Richard Eric Davis, MD, Jason R Westin, MD

Blood (2015) 126 (23): 3965.

https://doi.org/10.1182/blood.V126.23.3965.3965

Published: 2015

Journal Articles

Studies of the Proteasome Inhibitor Sensitivity Modulator Tight Junction Protein 1 Highlight a Role for Signaling through the Epidermal Growth Factor Receptor in Determining Proteasome Capacity

Blood (2014) 124 (21): 3414.

https://doi.org/10.1182/blood.V124.21.3414.3414

Published: 2014

Journal Articles

Double Hit Lymphoma: M.D. Anderson Experience

Yasuhiro Oki, MD, Mansoor Noorani, Richard Eric Davis, MD, Sattva S. Neelapu, MD, Alma Rodriguez, M.D., Fredrick B Hagemeister, MD, Nathan Fowler, MD, Michael Wang, MD, Michelle A. Fanale, MD, Felipe Samaniego, M.D., M.P.H, Bouthaina S. Dabaja, MD, Chelsea Pinnix, M.D., Larry W. Kwak, MD, PhD, Jorge E Romaguera, MD, Issa Khouri, MD, Jason R. Westin, MD, Luis E Fayad

Blood (2013) 122 (21): 1776.

https://doi.org/10.1182/blood.V122.21.1776.1776

Published: 2013

Journal Articles

Role of IL-4 in Inducing Immunosuppressive Tumor Microenvironment in Follicular Lymphoma

Seema Rawal, PhD, Hyun Jun Park, Fuliang Chu, Min Zhang, Durga Nattamai, Shibi Chakravarthy Kannan, Rakesh Sharma, David A Delgado, Tina Chou, Richard Eric Davis, MD, Sattva S. Neelapu, MD

Blood (2011) 118 (21): 771.

https://doi.org/10.1182/blood.V118.21.771.771

Published: 2011

Journal Articles

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

Enrico Derenzini, MD, Manuela Lemoine, PhD, Elisa Brighenti, PhD, Richard Eric Davis, MD, Pier Luigi Zinzani, MD, Anas Younes, MD

Blood (2011) 118 (21): 2731.

https://doi.org/10.1182/blood.V118.21.2731.2731

Published: 2011

NARROW

Thymidine Phosphorylase Exerts Complex Effects on Bone Resorption and Formation in Myeloma

Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML

Silencing TG2 in Acute Myeloid Leukemia. Possible Role of TG2 in Microenvironment-Mediated Chemoresistance

Gene Expression Profiling Predicts Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Molecular Aspects of Tonic B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma Provide Biomarkers and Targets for Specific Inhibition

The Risk of Central Nervous System (CNS) Relapses in Patients with Peripheral T-Cell Lymphoma

ONC201 Overcomes Chemotherapy Resistance By Upregulation of Bim in Multiple Myeloma

ONC212 Is a Potent Member of the Imipridone Class of Anti-Cancer Compounds That Induces p53-Independent Apoptosis in Hematological Malignancies

Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience

The Survival Outcome of the Patients with Relapsed/Refractory Anaplastic Large-Cell Lymphoma

Management Strategies and Outcomes for Very Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Use of Gene Expression Profiling May Predict Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma

ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response

The Survival Outcome of the Patients with Relapsed/Refractory PTCL-NOS and AITL

The Clinical Outcome of Newly Diagnosed Patients >60 Years of Age with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Standard or Liposomal Chemotherapies

Studies of the Proteasome Inhibitor Sensitivity Modulator Tight Junction Protein 1 Highlight a Role for Signaling through the Epidermal Growth Factor Receptor in Determining Proteasome Capacity

Double Hit Lymphoma: M.D. Anderson Experience

Role of IL-4 in Inducing Immunosuppressive Tumor Microenvironment in Follicular Lymphoma

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only